BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25511108)

  • 1. Esophageal cancer-related gene-4 (ECRG4) interactions with the innate immunity receptor complex.
    Podvin S; Dang X; Meads M; Kurabi A; Costantini T; Eliceiri BP; Baird A; Coimbra R
    Inflamm Res; 2015 Feb; 64(2):107-18. PubMed ID: 25511108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open reading frame mining identifies a TLR4 binding domain in the primary sequence of ECRG4.
    Dang X; Coimbra R; Mao L; Podvin S; Li X; Yu H; Costantini TW; Zeng X; Larocca D; Eliceiri BP; Baird A
    Cell Mol Life Sci; 2019 Dec; 76(24):5027-5039. PubMed ID: 31190084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer.
    Ryu JK; Kim SJ; Rah SH; Kang JI; Jung HE; Lee D; Lee HK; Lee JO; Park BS; Yoon TY; Kim HM
    Immunity; 2017 Jan; 46(1):38-50. PubMed ID: 27986454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary preconditioning, injury, and inflammation modulate expression of the candidate tumor suppressor gene ECRG4 in lung.
    Kao S; Shaterian A; Cauvi DM; Dang X; Chun HB; De Maio A; Costantini TW; Coimbra R; Eliceiri BP; Baird A
    Exp Lung Res; 2015 Apr; 41(3):162-72. PubMed ID: 25513848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14.
    Kim SJ; Kim HM
    BMB Rep; 2017 Feb; 50(2):55-57. PubMed ID: 28115037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages.
    Baird A; Coimbra R; Dang X; Lopez N; Lee J; Krzyzaniak M; Winfield R; Potenza B; Eliceiri BP
    J Leukoc Biol; 2012 May; 91(5):773-81. PubMed ID: 22396620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computationally Designed Bispecific MD2/CD14 Binding Peptides Show TLR4 Agonist Activity.
    Michaeli A; Mezan S; Kühbacher A; Finkelmeier D; Elias M; Zatsepin M; Reed SG; Duthie MS; Rupp S; Lerner I; Burger-Kentischer A
    J Immunol; 2018 Dec; 201(11):3383-3391. PubMed ID: 30348734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ECRG4 is associated with lower proliferative potential of esophageal cancer cells.
    Matsuzaki J; Torigoe T; Hirohashi Y; Tamura Y; Asanuma H; Nakazawa E; Saka E; Yasuda K; Takahashi S; Sato N
    Pathol Int; 2013 Aug; 63(8):391-7. PubMed ID: 23957914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring Neutrophil-Expressed Cell Surface Esophageal Cancer Related Gene-4 after Severe Burn Injury.
    Costantini TW; Coimbra R; Lopez NE; Lee JG; Potenza B; Smith A; Baird A; Eliceiri BP
    Surg Infect (Larchmt); 2015 Dec; 16(6):669-74. PubMed ID: 26460850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Md1 and Rp105 regulate innate immunity and viral resistance in zebrafish.
    Candel S; Sepulcre MP; Espín-Palazón R; Tyrkalska SD; de Oliveira S; Meseguer J; Mulero V
    Dev Comp Immunol; 2015 Jun; 50(2):155-65. PubMed ID: 25681741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counter regulation of ECRG4 gene expression by hypermethylation-dependent inhibition and the Sp1 transcription factor-dependent stimulation of the c2orf40 promoter.
    Dang X; Zeng X; Coimbra R; Eliceiri BP; Baird A
    Gene; 2017 Dec; 636():103-111. PubMed ID: 28870864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of TLR4 Receptor Complex in the Regulation of the Innate Immune Response by Fibronectin.
    Zheng M; Ambesi A; McKeown-Longo PJ
    Cells; 2020 Jan; 9(1):. PubMed ID: 31952223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal cancer-related gene 4 at the interface of injury, inflammation, infection, and malignancy.
    Baird A; Lee J; Podvin S; Kurabi A; Dang X; Coimbra R; Costantini T; Bansal V; Eliceiri BP
    Gastrointest Cancer; 2014; 2014(4):131-142. PubMed ID: 25580077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-processed Ecrg4 recruits myeloid cells and induces antitumorigenic inflammation.
    Lee J; Dang X; Borboa A; Coimbra R; Baird A; Eliceiri BP
    Neuro Oncol; 2015 May; 17(5):685-96. PubMed ID: 25378632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polybacterial immunomodulator Respivax restores the inductive function of innate immunity in patients with recurrent respiratory infections.
    Nikolova M; Stankulova D; Taskov H; Nenkov P; Maximov V; Petrunov B
    Int Immunopharmacol; 2009 Apr; 9(4):425-32. PubMed ID: 19186221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ECRG4 cleavage product augurin binds the endotoxin receptor and influences the innate immune response during otitis media.
    Kurabi A; Hur DG; Pak K; Gibson M; Webster NJG; Baird A; Eliceiri BP; Ryan AF
    Front Genet; 2022; 13():932555. PubMed ID: 36092940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4.
    Dang X; Podvin S; Coimbra R; Eliceiri B; Baird A
    Cell Tissue Res; 2012 Jun; 348(3):505-14. PubMed ID: 22526622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.
    Li LW; Yu XY; Yang Y; Zhang CP; Guo LP; Lu SH
    Int J Cancer; 2009 Oct; 125(7):1505-13. PubMed ID: 19521989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses.
    Sabroe I; Jones EC; Usher LR; Whyte MK; Dower SK
    J Immunol; 2002 May; 168(9):4701-10. PubMed ID: 11971020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.